The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Novel Proteinaceous Infectious Particles Cause Scrapie
Abstract
After infection and a prolonged incubation period, the scrapie agent causes a degenerative disease of the central nervous system in sheep and goats. Six lines of evidence including sensitivity to proteases demonstrate that this agent contains a protein that is required for infectivity. Although the scrapie agent is irreversibly inactivated by alkali, five procedures with more specificity for modifying nucleic acids failed to cause inactivation. The agent shows heterogeneity with respect to size, apparently a result of its hydrophobicity; the smallest form may have a molecular weight of 50,000 or less. Because the novel properties of the scrapie agent distinguish it from viruses, plasmids, and viroids, a new term "prion" is proposed to denote a small pro teinaceous in fectious particle which is resistant to inactivation by most procedures that modify nucleic acids. Knowledge of the scrapie agent structure may have significance for understanding the causes of several degenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Physical chemistry of macromolecules
(2007) · Choice Reviews Online · doi:10.5860/choice.45-2038 · Cited by 3,765
Central Dogma of Molecular Biology
CRICK, F. (1970) · Nature · doi:10.1038/227561a0 · Cited by 3,444
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Nature of the Scrapie Agent: Self-replication and Scrapie
GRIFFITH, J. S. (1967) · Nature · doi:10.1038/2151043a0 · Cited by 1,161
Experimental Transmission of a Kuru-like Syndrome to Chimpanzees
GAJDUSEK, D. C., GIBBS, C. J., & ALPERS, M. (1966) · Nature · doi:10.1038/209794a0 · Cited by 837
FURTHER STUDIES ON THE ALKYLATION OF NUCLEIC ACIDS AND THEIR CONSTITUENT NUCLEOTIDES
LAWLEY, P., & BROOKES, P. (1963) · Biochemical Journal · doi:10.1042/bj0890127 · Cited by 797
Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee
Gibbs, C. J., Gajdusek, D. C., Asher, D. M., Alpers, M. P., Beck, E., Daniel, P. M., & Matthews, W. B. (1968) · Science · doi:10.1126/science.161.3839.388 · Cited by 779
Does the Agent of Scrapie Replicate without Nucleic Acid ?
ALPER, T., CRAMP, W. A., HAIG, D. A., & CLARKE, M. C. (1967) · Nature · doi:10.1038/214764a0 · Cited by 691
Unconventional Viruses and the Origin and Disappearance of Kuru
Gajdusek, D. C. (1977) · Science · doi:10.1126/science.142303 · Cited by 671
Research works printed but not linked: 88
- CAN MED ASS J 124: 1436 (1981).
- ADAMS, D.H., BIOCH SOC T 1: 1061 (1973). · doi:10.1042/bst0011061
- ADAMS, D.H., BRITISH MEDICAL JOURNAL 3: 1973 (1967).
- ADAMS, D.H., NATURE OF SCRAPIE AGENT - A REVIEW OF RECENT PROGRESS, PATHOLOGIE BIOLOGIE 18: 559 (1970).
- ALPERS, M, SLOW TRANSMISSIBLE D 1: 67 (1979).
- ANDREWS, P, METHODS OF BIOCHEMICAL ANALYSIS 18: 1 (1971).
- BARINGER, J.R., REGIONAL NEUROPATHOLOGY AND TITERS IN HAMSTER SCRAPIE, JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 40: 329 (1981).
- BASTIAN, F.O., SPIROPLASMA-LIKE INCLUSIONS IN CREUTZFELDT-JAKOB DISEASE, ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 103: 665 (1979).
- BASTIAN, F.O., ADDITIONAL EVIDENCE OF SPIROPLASMA IN CREUTZFELDT-JAKOB DISEASE, LANCET 1: 660 (1981).
- BISHOP, J.M., ENEMIES WITHIN - THE GENESIS OF RETROVIRUS ONCOGENES, CELL 23: 5 (1981). · doi:10.1016/0092-8674(81)90263-4
- BORNSTEIN, P, SPECIFIC NONENZYMATIC CLEAVAGE OF BOVINE RIBONUCLEASE WITH HYDROXYLAMINE, JOURNAL OF BIOLOGICAL CHEMISTRY 245: 4854 (1970). · doi:10.1016/s0021-9258(18)62873-x
- Borrás, M.-T., Journal of General Virology 58: 263 (1982). · doi:10.1099/0022-1317-58-2-263
- BROWN, D.M., BASIC PRINCIPLES NUC 2: 1 (1974).
- BROWN, P, EFFECT OF DIFFERENT GRADIENT SOLUTIONS ON BUOYANT DENSITY OF SCRAPIE INFECTIVITY, PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 158: 513 (1978). · doi:10.3181/00379727-158-40236
- CHO, H.J., IS SCRAPIE AGENT A VIRUS, NATURE 262: 411 (1976). · doi:10.1038/262411a0
- CRAIG, R, THE THEORETICAL POSSIBILITY OF REVERSE TRANSLATION OF PROTEINS INTO GENES, JOURNAL OF THEORETICAL BIOLOGY 88: 757 (1981). · doi:10.1016/0022-5193(81)90250-2
- CUILLE, J, COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DES SCIENCES 208: 1058 (1939).
- DARLINGTON, C.D., VIRUS DISEASES NERVO: 133 (1969).
- DICKINSON, A.G., GENETICAL CONTROL OF CONCENTRATION OF ME7 SCRAPIE AGENT IN BRAIN OF MICE, JOURNAL OF COMPARATIVE PATHOLOGY 79: 15 (1969). · doi:10.1016/0021-9975(69)90021-8
- DICKINSON, A.G., GENETICAL CONTROL OF CONCENTRATION OF ME7 SCRAPIE AGENT IN MOUSE SPLEEN, JOURNAL OF COMPARATIVE PATHOLOGY 79: 363 (1969). · doi:10.1016/0021-9975(69)90051-6
- DICKINSON, A.G., SLOW TRANSMISSIBLE D 1: 367 (1979).
- DICKINSON, A.G., SLOW VIRUS INFECTION: 3 (1977).
- DIENER, T.O., IS SCRAPIE AGENT A VIROID, NATURE-NEW BIOLOGY 235: 218 (1972).
- DIENER T.O. VIROIDS VIROID DISEA (1979). · doi:10.1016/b978-0-12-601950-6.50015-4
- FIELD, E.J., TRANSMISSION EXPERIMENTS WITH MULTIPLE SCLEROSIS - AN INTERIM REPORT, BRITISH MEDICAL JOURNAL 2: 564 (1966). · doi:10.1136/bmj.2.5513.564
- FIELD, E.J., DT Z NERVENHEILKUNDE 192: 265 (1967).
- FRANKLIN, R.M., INACTIVATION OF SOME ANIMAL VIRUSES BY HYDROXYLAMINE AND THE STRUCTURE OF RIBONUCLEIC ACID, NATURE 184: 343 (1959). · doi:10.1038/184343a0
- FREESE, E, HYDROXYLAMINE AS A MUTAGENIC AND INACTIVATING AGENT, JOURNAL OF MOLECULAR BIOLOGY 3: 133 (1961). · doi:10.1016/s0022-2836(61)80040-5
- GAJDUSEK, D.C., HUMAN DISEASES CAUSE: 231 (1978).
- GAJDUSEK, D.C., VIRUSES ENV: 79 (1978).
- GIANNONI, G, CRYSTALLIZATION OF DNA FROM DILUTE SOLUTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 62: 964 (1969).
- GIBBS, C.J., SLOW TRANSMISSIBLE D 2: 87 (1979).
- GORDON, W.S., VETERINARY RECORD 69: 1444 (1957).
- GORDON, W.S., VETERINARY RECORD 58: 516 (1946).
- GRAY, A, SPIROPLASMA AND CREUTZFELDT-JAKOB DISEASE, LANCET 2: 152 (1980).
- HAASE, A.T., INFECTIVITY OF VISNA VIRUS DNA, VIROLOGY 70: 65 (1976). · doi:10.1016/0042-6822(76)90236-1
- HADLOW, W.J., SCRAPIE AND KURU, LANCET 2: 289 (1959).
- HADLOW, W.J., VIROLOGIC AND NEUROHISTOLOGIC FINDINGS IN DAIRY GOATS AFFECTED WITH NATURAL SCRAPIE, VETERINARY PATHOLOGY 17: 187 (1980). · doi:10.1177/030098588001700207
- HAIG, D.A., SLOW LATENT TEMPERAT 2: 215 (1965).
- HOGAN, R.N., PROGRESSIVE RETINAL DEGENERATION IN SCRAPIE-INFECTED HAMSTERS - A LIGHT AND ELECTRON-MICROSCOPIC ANALYSIS, LABORATORY INVESTIGATION 44: 34 (1981).
- HUNTER, G.D., VIRAL AND NON-VIRAL PROPERTIES OF SCRAPIE AGENT, ANNALS OF CLINICAL RESEARCH 5: 262 (1973).
- HUNTER, G.D., ATTEMPTS TO RELEASE SCRAPIE AGENT FROM TISSUE DEBRIS, JOURNAL OF COMPARATIVE PATHOLOGY 77: 301 (1967). · doi:10.1016/0021-9975(67)90039-4
- HUNTER, G.D., SLOW TRANSMISSIBLE D 2: 365 (1979).
- KIMBERLIN, R.H., J GEN VIROL 1: 115 (1967).
- KIMBERLIN, R.H., EXPERIMENTAL SCRAPIE IN MOUSE - REVIEW OF AN IMPORTANT MODEL DISEASE, SCIENCE PROGRESS 63: 461 (1976).
- KIMBERLIN, R.H., SCRAPIE MOUSE: 1 (1976).
- KLEINKAUF, H, CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY 91: 129 (1981).
- LATARJET, R, SLOW TRANSMISSIBLE D 2: 387 (1979).
- LEWIN, P, SCRAPIE - INFECTIVE PEPTIDE, LANCET 1: 748 (1972).
- MACKAY, JMK, DETECTION OF SCRAPIE AGENT IN TISSUES OF NORMAL MICE, NATURE 219: 182 (1968). · doi:10.1038/219182a0
- MALONE, T.G., MEMBRANE-FREE SCRAPIE ACTIVITY, JOURNAL OF VIROLOGY 25: 933 (1978). · doi:10.1128/jvi.25.3.933-935.1978
- MALONE, T.G., EVIDENCE FOR THE LOW-MOLECULAR WEIGHT NATURE OF SCRAPIE AGENT, NATURE 278: 575 (1979). · doi:10.1038/278575a0
- MANUELIDIS, E.E., SLOW TRANSMISSIBLE D 2: 147 (1979).
- MARSH, R.F., EVIDENCE FOR AN ESSENTIAL DNA COMPONENT IN SCRAPIE AGENT, NATURE 275: 146 (1978). · doi:10.1038/275146a0
- MCKINLEY, M.P., REVERSIBLE CHEMICAL MODIFICATION OF THE SCRAPIE AGENT, SCIENCE 214: 1259 (1981). · doi:10.1126/science.6795721
- MEANS, G.E., CHEM MODIFICATION PR: 1 (1971).
- MFADYEAN, J, J COMP PATHOL 31: 102 (1918). · doi:10.1016/s0368-1742(18)80015-7
- MILLSON, G.C., SLOW VIRUS DIS ANIMA: 243 (1976).
- MOULD, D.L., SCRAPIE IN MICE . STABILITY OF AGENT TO VARIOUS SUSPENDING MEDIA PH AND SOLVENT EXTRACTION, RESEARCH IN VETERINARY SCIENCE 6: 151 (1965). · doi:10.1016/s0034-5288(18)34749-0
- NARANG, H.K., RUTHENIUM RED AND LANTHANUM NITRATE A POSSIBLE TRACER AND NEGATIVE STAIN FOR SCRAPIE PARTICLES, ACTA NEUROPATHOLOGICA 29: 37 (1974). · doi:10.1007/bf00684389
- NOZTH, ACT, NATURE 191: 1242 (1961). · doi:10.1038/1911242a0
- PATTISON, I.H., FURTHER EXPERIMENTAL OBSERVATIONS ON SCRAPIE, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 71: 350 (1961). · doi:10.1016/s0368-1742(61)80040-4
- PATTISON, I.H., DETECTION OF SCRAPIE AGENT IN TISSUES OF NORMAL MICE WITH SPECIAL REFERENCE TO POSSIBILITY OF ACCIDENTAL LABORATORY CONTAMINATION, RESEARCH IN VETERINARY SCIENCE 12: 30 (1971). · doi:10.1016/s0034-5288(18)34235-8
- PATTISON, I.H., VETERINARY RECORD 80: 1 (1967).
- PHILLIPS, J.H., PROGRESS NUCLEIC ACI 7: 349 (1967).
- PRUSINER, S.B., AGING BRAIN DEMENTIA: 205 (1980).
- PRUSINER, S.B., GEL-ELECTROPHORESIS AND GLASS PERMEATION CHROMATOGRAPHY OF THE HAMSTER SCRAPIE AGENT AFTER ENZYMATIC DIGESTION AND DETERGENT EXTRACTION, BIOCHEMISTRY 19: 4892 (1980). · doi:10.1021/bi00562a029
- PRUSINER, S.B., NEUROCHEMISTRY CLIN: 73 (1980).
- PRUSINER, S.B., ELECTROPHORETIC PROPERTIES OF THE SCRAPIE AGENT IN AGAROSE GELS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 77: 2984 (1980).
- PRUSINER, S.B., SLOW TRANSMISSIBLE D 2: 425 (1979).
- QUALTIERE, L.F., RE-EXAMINATION OF HUMORAL TOLERANCE IN CHICKENS CONGENITALLY INFECTED WITH AN AVIAN-LEUKOSIS VIRUS, JOURNAL OF IMMUNOLOGY 122: 825 (1979). · doi:10.4049/jimmunol.122.3.825
- REYNOLDS, J.A., MEMBRANE RECEPTORS B 11: 33 (1981).
- ROHWER, R.G., SEARCH CAUSE MULTIPL: 333 (1980).
- ROSE, J.A., COMPREHENSIVE VIROLOGY 3: 1 (1974).
- SCHAFFER, F.L., ADV VIRUS RES 6: 159 (1959). · doi:10.1016/s0065-3527(08)60491-1
- SCHUSTER, H, INACTIVATING AND MUTAGENIC ACTION OF HYDROXYLAMINE ON TOBACCO MOSAIC VIRUS RIBONUCLEIC ACID, VIROLOGY 19: 421 (1963). · doi:10.1016/0042-6822(63)90035-7
- 10.1016/0042-6822(73)90224-9 · doi:10.1016/0042-6822(73)90224-9
- SIAKATOS, A.N., DISCOVERY OF A PARTICLE UNIQUE TO BRAIN AND SPLEEN SUBCELLULAR-FRACTIONS FROM SCRAPIE-INFECTED MICE, JOURNAL OF GENERAL VIROLOGY 43: 417 (1979). · doi:10.1099/0022-1317-43-2-417
- SOMERVILLE, R.A., CHANGES IN A PROTEIN-NUCLEIC ACID COMPLEX FROM SYNAPTIC PLASMA-MEMBRANE OF SCRAPIE-INFECTED MOUSE-BRAIN, BIOCHEMICAL SOCIETY TRANSACTIONS 4: 1112 (1976). · doi:10.1042/bst0041112
- 10.1126/science.81.2113.644 · doi:10.1126/science.81.2113.644
- STOCKMAN, S, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 26: 317 (1913). · doi:10.1016/s0368-1742(13)80060-4
- TESSMAN, I, MUTAGENIC TREATMENT OF DOUBLE- AND SINGLE-STRANDED DNA PHAGES T4 AND S13 WITH HYDROXYLAMINE, VIROLOGY 35: 330 (1968). · doi:10.1016/0042-6822(68)90275-4
- VINOGRAD, J, BUOYANT BEHAVIOR OF VIRAL AND BACTERIAL DNA IN ALKALINE CSCL, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 49: 12 (1963).
- WAKSMAN, B.H., TOLERANCE, THYMUS, AND SUPPRESSOR T-CELLS, CLINICAL AND EXPERIMENTAL IMMUNOLOGY 28: 363 (1977).
- Parry, H. B., Virus Diseases and the Nervous System: 99 (1969).
- WILSON, D.R., STUDIES IN SCRAPIE, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 60: 267 (1950). · doi:10.1016/s0368-1742(50)80025-5
- YANG, V.W., A SMALL NUCLEAR RIBONUCLEOPROTEIN IS REQUIRED FOR SPLICING OF ADENOVIRAL EARLY RNA SEQUENCES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 78: 1371 (1981).
- ZLOTNIK, I, ACTA NEUROPATHOLOGICA 1: 61 (1962).
Cited by
Items 201–232 of 232
Liberski, P. P., Sikorska, B., Bratosiewicz-Wasik, J., Carleton Gajdusek, D., & Brown, P. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.016 · Cited by 125
Crystal structure of human prion protein bound to a therapeutic antibody
Antonyuk, S. V., Trevitt, C. R., Strange, R. W., Jackson, G. S., Sangar, D., Batchelor, M., Cooper, S., Fraser, C., Jones, S., Georgiou, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809170106 · Cited by 124
Aguzzi, A., & Zhu, C. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90605 · Cited by 122
THE PUBLIC HEALTH IMPACT OF PRION DISEASES
Belay, E. D., & Schonberger, L. B. (2005) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144536 · Cited by 116
Kranich, J., Krautler, N. J., Falsig, J., Ballmer, B., Li, S., Hutter, G., Schwarz, P., Moos, R., Julius, C., Miele, G., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092401 · Cited by 110
Collinge, J., Whitfield, J., McKintosh, E., Frosh, A., Mead, S., Hill, A. F., Brandner, S., Thomas, D., & Alpers, M. P. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0068 · Cited by 110
Caries progression and inhibition in human and bovine root dentine in situ
Hara, A. T., Queiroz, C. S., Paes Leme, A. F., Serra, M. C., & Cury, J. A. (2003) · Caries Research · doi:10.1159/000072165 · Cited by 99
Ugalde, C. L., Finkelstein, D. I., Lawson, V. A., & Hill, A. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13772 · Cited by 92
Neurodegenerative diseases and exposure to the environmental metals Mn, Pb, and Hg
Charlet, L., Chapron, Y., Faller, P., Kirsch, R., Stone, A. T., & Baveye, P. C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.05.012 · Cited by 92
Choi, C. J., Kanthasamy, A., Anantharam, V., & Kanthasamy, A. G. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.06.004 · Cited by 88
Pulford, B., Reim, N., Bell, A., Veatch, J., Forster, G., Bender, H., Meyerett, C., Hafeman, S., Michel, B., Johnson, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011085 · Cited by 85
Tau prion-like propagation: state of the art and current challenges
Dujardin, S., & Hyman, B. T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9358-8_23 · Cited by 84
Truncated Prion Protein and Doppel Are Myelinotoxic in the Absence of Oligodendrocytic PrPC
Radovanovic, I., Braun, N., Giger, O. T., Mertz, K., Miele, G., Prinz, M., Navarro, B., & Aguzzi, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0328-05.2005 · Cited by 82
Bouybayoune, I., Mantovani, S., Del Gallo, F., Bertani, I., Restelli, E., Comerio, L., Tapella, L., Baracchi, F., Fernández-Borges, N., Mangieri, M., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004796 · Cited by 81
“This is a conformationally altered and aggregated isoform of the cellular prion protein (PrP) which propagates by imprinting its aberrant conformation onto native PrP molecules [6].”
BackgroundDiffusing protein binders to intrinsically disordered proteins
Liu, C., Wu, K., Choi, H., Han, H. L., Zhang, X., Watson, J. L., Ahn, G., Zhang, J. Z., Shijo, S., Good, L. L., et al. (2025) · Nature · doi:10.1038/s41586-025-09248-9 · Cited by 79
Liu, S., Hossinger, A., Heumüller, S.-E., Hornberger, A., Buravlova, O., Konstantoulea, K., Müller, S. A., Paulsen, L., Rousseau, F., Schymkowitz, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25855-2 · Cited by 72
Makarava, N., Chang, J. C.-Y., Molesworth, K., & Baskakov, I. V. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104783 · Cited by 64
Kuru with incubation periods exceeding two decades
Prusiner, S. B., Gajdusek, D. C., & Alpers, M. P. (1982) · Annals of Neurology · doi:10.1002/ana.410120102 · Cited by 63
Self-citationPhenotypic variability in human prion diseases
Ironside, J. W., Ritchie, D. L., & Head, M. W. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00697.x · Cited by 58
Cellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction
Miranzadeh Mahabadi, H., & Taghibiglou, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197058 · Cited by 52
Carlson, G. A., & Prusiner, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094861 · Cited by 51
Self-citationKuru: Genes, Cannibals and Neuropathology
Liberski, P. P., Sikorska, B., Lindenbaum, S., Goldfarb, L. G., McLean, C., Hainfellner, J. A., & Brown, P. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182444efd · Cited by 59
“This question remained open until the ‘‘protein-only’’ theory was formulated (18, 19), a protein that copurified with the infectivity was found (20), and S.”
BackgroundMicroglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain
Bradford, B. M., McGuire, L. I., Hume, D. A., Pridans, C., & Mabbott, N. A. (2022) · Glia · doi:10.1002/glia.24244 · Cited by 44
Zhu, C., Herrmann, U. S., Li, B., Abakumova, I., Moos, R., Schwarz, P., Rushing, E. J., Colonna, M., & Aguzzi, A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.019 · Cited by 44
Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
Nuvolone, M., Sorce, S., Schwarz, P., & Aguzzi, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117208 · Cited by 39
Cystatin F is a biomarker of prion pathogenesis in mice
Nuvolone, M., Schmid, N., Miele, G., Sorce, S., Moos, R., Schori, C., Beerli, R. R., Bauer, M., Saudan, P., Dietmeier, K., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171923 · Cited by 25
Lessons of kuru research: background to recent studies with some personal reflections
Collinge, J. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0121 · Cited by 25
Diffusing protein binders to intrinsically disordered proteins
Liu, C., Wu, K., Choi, H., Han, H., Zhang, X., Watson, J. L., Shijo, S., Bera, A. K., Kang, A., Brackenbrough, E., et al. (2024) · doi:10.1101/2024.07.16.603789 · Cited by 24
Muth, C., Schröck, K., Madore, C., Hartmann, K., Fanek, Z., Butovsky, O., Glatzel, M., & Krasemann, S. (2017) · Brain Pathology · doi:10.1111/bpa.12441 · Cited by 23
Transport of prions in the peripheral nervous system: pathways, cell types, and mechanisms
Koshy, S. M., Kincaid, A. E., & Bartz, J. C. (2022) · Viruses · doi:10.3390/v14030630 · Cited by 14
Loss of Homeostatic Microglia Signature in Prion Diseases
Wang, Y., Hartmann, K., Thies, E., Mohammadi, B., Altmeppen, H., Sepulveda-Falla, D., Glatzel, M., & Krasemann, S. (2022) · Cells · doi:10.3390/cells11192948 · Cited by 12
“formation and disease progression [18] (Figure 1A).”
BackgroundGarcés, M., Guijarro, I. M., Ritchie, D. L., Badiola, J. J., & Monzón, M. (2021) · Pathogens · doi:10.3390/pathogens10050596 · Cited by 3
Metadata
- Authors
- Prusiner, S. B.
- Venue
- Science
- Published
- 1982-04-09
- Volume
- 216
- Issue
- 4542
- Pages
- 136-144
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2013679718
- Cited by
- 5,118
- References
- 83
- FWCI
- 17.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.